Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European...

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Public Health Initiatives

Background:

• Post-acute coronary syndrome (ACS) patients face elevated cardiovascular risk, yet often undertreated with high-intensity statins.
• Suboptimal low-density lipoprotein cholesterol (LDL-C) control persists in many ACS patients despite guideline recommendations.
• Underdiagnosis of familial hypercholesterolemia (FH) in ACS populations contributes to treatment gaps.

Purpose of the Study:

• To evaluate the impact of local European initiatives on in-hospital and post-discharge lipid management for ACS patients.
• To assess the effectiveness of standardized protocols in improving lipid levels and adherence to high-intensity statin therapy.
• To address the underestimation of familial hypercholesterolemia in high-risk cardiovascular patient cohorts.

Main Methods:

• Implementation of dedicated lipid management strategies during hospitalization for ACS.
• Establishment of standardized post-discharge follow-up protocols for ACS patients.
• Monitoring of LDL-C levels and high-intensity statin initiation rates.

Main Results:

• Optimized in-hospital therapy and dedicated follow-up protocols led to significant improvements in lipid levels.
• Increased adherence to high-intensity statin therapy was observed within these initiatives.
• Potential for reduced recurrent cardiovascular events in very high-risk ACS patients.

Conclusions:

• Targeted lipid management interventions during and after hospitalization are effective in very high-risk ACS patients.
• Standardized protocols and improved guideline adherence can enhance therapeutic outcomes.
• Addressing lipid management gaps, including FH, is crucial for secondary prevention in ACS.